CKD-703

· Chong Kun Dang Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-703, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer [Phase 1, Phase 2]